[Hypersensitivity reactions to chemotherapeutic antineoplastic agents]

Area of Science:

• Oncology
• Pharmacology
• Immunology

Background:

• Hypersensitivity reactions to chemotherapy are often underestimated.
• Severe reactions can occur with specific agents like L-asparaginase, taxanes, and platinum salts.
• These reactions may involve respiratory and cardiovascular systems, necessitating treatment cessation.

Purpose of the Study:

• To highlight the clinical significance of hypersensitivity reactions to antineoplastic agents.
• To review available strategies for preventing and managing chemotherapy-induced hypersensitivity.
• To emphasize the importance of managing these reactions to ensure treatment continuity.

Main Methods:

• Literature review of hypersensitivity reactions to chemotherapeutic agents.
• Analysis of management strategies including drug substitution, premedication, and desensitization.
• Discussion of clinical implications and patient outcomes.

Main Results:

• While rare for most agents, hypersensitivity to L-asparaginase, taxanes, and platinum salts can be severe.
• Drug substitution with biotechnologically derived or similar agents is a primary preventive measure.
• Preventive protocols involving corticosteroids and antihistamines are effective.
• Desensitization protocols show success for taxanes and platinum salts.

Conclusions:

• Hypersensitivity reactions to specific chemotherapeutic agents require careful consideration and management.
• Proactive strategies can mitigate risks and allow for continued essential cancer therapy.
• Effective management ensures better patient outcomes by preventing treatment interruptions.